These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

400 related articles for article (PubMed ID: 29786861)

  • 1. Temporally feathered intensity-modulated radiation therapy: A planning technique to reduce normal tissue toxicity.
    López Alfonso JC; Parsai S; Joshi N; Godley A; Shah C; Koyfman SA; Caudell JJ; Fuller CD; Enderling H; Scott JG
    Med Phys; 2018 Jul; 45(7):3466-3474. PubMed ID: 29786861
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Technical Note: A step-by-step guide to Temporally Feathered Radiation Therapy planning for head and neck cancer.
    Parsai S; Qiu RLJ; Qi P; Alfonso JCL; Donaghue J; Murray E; Majkszak D; Dorio N; Fuller CD; Brock K; Koyfman S; Woody N; Joshi N; Scott JG
    J Appl Clin Med Phys; 2020 Jul; 21(7):209-215. PubMed ID: 32383296
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Dosimetric Evaluation of Incorporating Patient Geometric Variations Into Adaptive Plan Optimization Through Probabilistic Treatment Planning in Head and Neck Cancers.
    Liu Q; Liang J; Zhou D; Krauss DJ; Chen PY; Yan D
    Int J Radiat Oncol Biol Phys; 2018 Jul; 101(4):985-997. PubMed ID: 29976511
    [TBL] [Abstract][Full Text] [Related]  

  • 4. In vivo assessment of the safety of standard fractionation Temporally Feathered Radiation Therapy (TFRT) for head and neck squamous cell carcinoma: An R-IDEAL Stage 1/2a first-in-humans/feasibility demonstration of new technology implementation.
    Parsai S; Qiu RLJ; Qi P; Sedor G; Fuller CD; Murray E; Majkszak D; Dorio N; Koyfman S; Woody N; Joshi N; Scott JG
    Radiother Oncol; 2021 Oct; 163():39-45. PubMed ID: 34333086
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Dosimetric comparison between 2-dimensional radiation therapy and intensity modulated radiation therapy in treatment of advanced T-stage nasopharyngeal carcinoma: to treat less or more in the planning organ-at-risk volume of the brainstem and spinal cord.
    Chau RM; Teo PM; Kam MK; Leung SF; Cheung KY; Chan AT
    Med Dosim; 2007; 32(4):263-70. PubMed ID: 17980826
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Intensity-modulated radiation therapy for pancreatic and prostate cancer using pulsed low-dose rate delivery techniques.
    Li J; Lang J; Wang P; Kang S; Lin MH; Chen X; Chen F; Guo M; Chen L; Ma CM
    Med Dosim; 2014; 39(4):330-6. PubMed ID: 25087084
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Volumetric intensity-modulated arc therapy vs conventional intensity-modulated radiation therapy in nasopharyngeal carcinoma: a dosimetric study.
    White P; Chan KC; Cheng KW; Chan KY; Chau MC
    J Radiat Res; 2013 May; 54(3):532-45. PubMed ID: 23188186
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Modeling the dosimetry of organ-at-risk in head and neck IMRT planning: an intertechnique and interinstitutional study.
    Lian J; Yuan L; Ge Y; Chera BS; Yoo DP; Chang S; Yin F; Wu QJ
    Med Phys; 2013 Dec; 40(12):121704. PubMed ID: 24320490
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Treatment plan comparison between helical tomotherapy and MLC-based IMRT using radiobiological measures.
    Mavroidis P; Ferreira BC; Shi C; Lind BK; Papanikolaou N
    Phys Med Biol; 2007 Jul; 52(13):3817-36. PubMed ID: 17664579
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Simultaneous beam geometry and intensity map optimization in intensity-modulated radiation therapy.
    Lee EK; Fox T; Crocker I
    Int J Radiat Oncol Biol Phys; 2006 Jan; 64(1):301-20. PubMed ID: 16289912
    [TBL] [Abstract][Full Text] [Related]  

  • 11. 4π plan optimization for cortical-sparing brain radiotherapy.
    Murzin VL; Woods K; Moiseenko V; Karunamuni R; Tringale KR; Seibert TM; Connor MJ; Simpson DR; Sheng K; Hattangadi-Gluth JA
    Radiother Oncol; 2018 Apr; 127(1):128-135. PubMed ID: 29519628
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Dependence of achievable plan quality on treatment technique and planning goal refinement: a head-and-neck intensity modulated radiation therapy application.
    Qi XS; Ruan D; Lee SP; Pham A; Kupelian P; Low DA; Steinberg M; Demarco J
    Int J Radiat Oncol Biol Phys; 2015 Mar; 91(4):817-24. PubMed ID: 25752396
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Chest wall desmoid tumours treated with definitive radiotherapy: a plan comparison of 3D conformal radiotherapy, intensity-modulated radiotherapy and volumetric-modulated arc radiotherapy.
    Liu J; Ng D; Lee J; Stalley P; Hong A
    Radiat Oncol; 2016 Mar; 11():34. PubMed ID: 26935470
    [TBL] [Abstract][Full Text] [Related]  

  • 14. An integrated strategy of biological and physical constraints in biological optimization for cervical carcinoma.
    Feng Z; Tao C; Zhu J; Chen J; Yu G; Qin S; Yin Y; Li D
    Radiat Oncol; 2017 Apr; 12(1):64. PubMed ID: 28376900
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Experience-based quality control of clinical intensity-modulated radiotherapy planning.
    Moore KL; Brame RS; Low DA; Mutic S
    Int J Radiat Oncol Biol Phys; 2011 Oct; 81(2):545-51. PubMed ID: 21277097
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Forward treatment planning for modulated electron radiotherapy (MERT) employing Monte Carlo methods.
    Henzen D; Manser P; Frei D; Volken W; Neuenschwander H; Born EJ; Lössl K; Aebersold DM; Stampanoni MF; Fix MK
    Med Phys; 2014 Mar; 41(3):031712. PubMed ID: 24593716
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Improving target dose coverage and organ-at-risk sparing in intensity-modulated radiotherapy of advanced laryngeal cancer by a simple optimization technique.
    Lu JY; Wu LL; Zhang JY; Zheng J; Cheung ML; Ma CC; Xie LX; Huang BT
    Br J Radiol; 2015 Feb; 88(1046):20140654. PubMed ID: 25494885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Protons offer reduced normal-tissue exposure for patients receiving postoperative radiotherapy for resected pancreatic head cancer.
    Nichols RC; Huh SN; Prado KL; Yi BY; Sharma NK; Ho MW; Hoppe BS; Mendenhall NP; Li Z; Regine WF
    Int J Radiat Oncol Biol Phys; 2012 May; 83(1):158-63. PubMed ID: 22245197
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Radiobiological model-based approach to determine the potential of dose-escalated robust intensity-modulated proton radiotherapy in reducing gastrointestinal toxicity in the treatment of locally advanced unresectable pancreatic cancer of the head.
    Raturi VP; Hojo H; Hotta K; Baba H; Takahashi R; Rachi T; Nakamura N; Zenda S; Motegi A; Tachibana H; Ariji T; Motegi K; Nakamura M; Okumura M; Hirano Y; Akimoto T
    Radiat Oncol; 2020 Jun; 15(1):157. PubMed ID: 32571379
    [TBL] [Abstract][Full Text] [Related]  

  • 20. An in silico planning study comparing doses and estimated risk of toxicity in 3D-CRT, IMRT and proton beam therapy of patients with thymic tumours.
    Lideståhl A; Mondlane G; Gubanski M; Lind PA; Siegbahn A
    Phys Med; 2019 Apr; 60():120-126. PubMed ID: 31000071
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 20.